DDW’s Megan Thomas speaks to Dr Lucas Thompson, Senior Director of Research at Tune Therapeutics, about the advancements in cell line development and how biotechnologies can enhance the precision and efficiency of therapeutic protein production. MT: What are the benefits cell line development is bringing to biopharmaceutical developers? LT: For induced pluripotent stem cell (iPSC) […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!